South Korea will invest 37.47 billion won in developing a solar-powered drone that could carry over 20 kilograms in the stratosphere and with natural disaster monitoring capability by 2025.
The drone will serve as an affordable alternative to their observation satellites, according to the Ministry of Science and ICT. It also won't create any space trash.
The ministry added that the solar-powered drone will be able to continuously fly in the stratosphere for over one month.
Last year, the solar-powered drone that the Korea Aerospace Research Institute has been developing since 2010 completed a 53-hour flight that included 16 hours in the stratosphere, which is 10 to 50 kilometers above the Earth's surface.
South Korea plans to commercialize flying drone taxis by 2025.


Astronomers have discovered another puzzling interstellar object − this third one is big, bright and fast
Trump Signs Executive Order to Boost AI Research in Childhood Cancer
Asian Markets Stabilize as Wall Street Rebounds and Rate Concerns Ease
U.S. Futures Steady as Rate-Cut Bets Rise on Soft Labor Data
NASA Partners with Katalyst to Save Swift Observatory with Innovative Docking Mission
Dollar Slides to Five-Week Low as Asian Stocks Struggle and Markets Bet on Fed Rate Cut
SpaceX’s Starship Completes 11th Test Flight, Paving Way for Moon and Mars Missions
Asian Currencies Steady as Rupee Hits Record Low Amid Fed Rate Cut Bets
China’s Services Sector Posts Slowest Growth in Five Months as Demand Softens
Dollar Holds Steady as Markets Shift Focus to 2026 Rate Cut Expectations
Kennedy Sets September Deadline to Uncover Autism Causes Amid Controversy
Gold Prices Steady as Markets Await Key U.S. Data and Expected Fed Rate Cut
Oil Prices Rise as Ukraine Targets Russian Energy Infrastructure
Gold Prices Edge Higher as Markets Await Key U.S. PCE Inflation Data
Eli Lilly’s Inluriyo Gains FDA Approval for Advanced Breast Cancer Treatment
European Oil & Gas Stocks Face 2026 With Cautious Outlook Amid Valuation Pressure
Cogent Biosciences Soars 120% on Breakthrough Phase 3 Results for Bezuclastinib in GIST Treatment 



